Dr. Holly Hunsberger

Holly is a postdoctoral scientist with a dual appointment at Columbia University and the New York State Psychiatric Institute (NYSPI/RFMH). She received her PhD from West Virginia University in Dr. Miranda Reed’s laboratory. There, she studied glutamate’s role in Alzheimer’s disease pathology using novel microelectrode array technology. She is now in Dr. Christine Denny’s laboratory, where she recently received a K99/R00 to study the sex-specific impact of anxiety on Alzheimer’s disease progression. Holly also has a fellowship with the Columbia Technology Ventures office where she works on early stage technology assessments, writing marketing abstracts, and preparing marketing campaigns. More recently, she was awarded SfN’s trainee development award and is one of the top 15 candidates in the new SfN leadership development program.